Transcriptomics

Dataset Information

0

Dual inhibition of G9a and DNMT1 Enhances Cell Reprogramming Promoting Induction of Mesenchymal-to-Epithelial Transition and Facilitating Transcription Factor Engagement in the Genome.


ABSTRACT: The combination of defined factors with small molecules targeting epigenetic factors is a strategy that has been shown to enhance optimal derivation of human iPSCs and could be used for therapeutic and regenerative medicine applications. In this study, we showed that a new first-in-class dual G9a/DNMT inhibitor CM272 compound improves the standard four-factor reprogramming efficiency of human fibroblast. The use of CM272 facilitates the generation of iPSC with only two factors, OCT4 and SOX2, allowing the removal of potentially oncogenic factors such as cMYC or KLF4. Taking a closer look at the early events occurring during cell reprogramming we demonstrated that treatment with our G9a/DNMT dual inhibitor induces heterochromatin relaxation, facilitates the engagement of OCT4 and SOX2 transcription factors to the genome and promotes mesenchymal to epithelial transition during cell reprogramming. Thus, the use of this new G9a/DNMT dual inhibitor compound may represent an interesting alternative for improving cell reprogramming.

ORGANISM(S): Homo sapiens

PROVIDER: GSE95307 | GEO | 2018/01/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-09-17 | E-GEOD-61694 | biostudies-arrayexpress
2020-11-01 | GSE144183 | GEO
2019-06-18 | GSE103980 | GEO
2019-06-18 | GSE103979 | GEO
2019-06-18 | GSE103978 | GEO
2019-06-18 | GSE119396 | GEO
2013-05-28 | E-GEOD-47441 | biostudies-arrayexpress
2020-01-21 | PXD015756 | Pride
2024-09-02 | BIOMD0000000210 | BioModels
2024-09-02 | BIOMD0000000209 | BioModels